$New-onset refractory status epilepticus (NORSE) — The potential role for immunotherapy$

New-onset refractory status epilepticus (NORSE) — The potential role for immunotherapy

Abstract New-onset refractory status epilepticus (NORSE) is defined as a state of persistent seizures with no identifiable etiology in patients without preexisting epilepsy that lasts longer than 24 h despite optimal therapy. Management of NORSE is challenging, and the role of immunotherapy (IT) is...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Epilepsy & behavior 2015-06, Vol.47, p.17-23
Hauptverfasser:	Khawaja, Ayaz M, DeWolfe, Jennifer L, Miller, David W, Szaflarski, Jerzy P
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anticonvulsants - therapeutic use Autoantibodies Case-Control Studies Chemotherapy Female Glutamate Decarboxylase Humans Immunoglobulins, Intravenous - therapeutic use Immunotherapy Male Middle Aged Neurology NORSE Outcome Prospective Studies Receptors, N-Methyl-D-Aspartate - immunology Seizures - complications Status epilepticus Status Epilepticus - diagnosis Status Epilepticus - drug therapy Status Epilepticus - therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!